Biomarin Pharmaceutical INC
SEC CIK 1048477 · BMRN · last insider filing 2026-06-04
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Dere Willard H | Director | filed 2016 - 2026 |
| Clark IAN T | Director | filed 2025 - 2026 |
| Walbert Timothy P | Director | filed 2025 - 2026 |
| Hombach Robert J. | Director | filed 2017 - 2026 |
| Countouriotis Athena | Director | filed 2023 - 2026 |
| Enyedy Mark J | Director | filed 2023 - 2026 |
| Ho Maykin | Director | filed 2021 - 2026 |
| Bodem Barbara W. | Director | filed 2023 - 2026 |
| Anderson Elizabeth M | Director | filed 2019 - 2026 |
| Hardy Alexander | Director · Chief Executive Officer | filed 2023 - 2026 |
| Meier Richard A | Director | filed 2006 - 2026 |
| Heron Elaine J | Director | filed 2006 - 2024 |
| Pyott David E I | Director | filed 2016 - 2024 |
| Bienaime Jean Jacques | Director · Chief Executive Officer | filed 2006 - 2024 |
| Slamon Dennis | Director | filed 2014 - 2024 |
| Lawlis V Bryan | Director | filed 2007 - 2023 |
| Alles Mark J | Director | filed 2022 - 2023 |
| Grey Michael G | Director | filed 2006 - 2021 |
| Lewis Alan | Director | filed 2006 - 2019 |
| Falberg Kathryn E | Director | filed 2016 - 2016 |
| Lapalme Pierre | Director | filed 2006 - 2015 |
| Bate Kenneth | Director | filed 2010 - 2015 |
| Young William D | Director | filed 2010 - 2015 |
| Klein Joseph III | Director | filed 2006 - 2010 |
| Cristiani Franz L | Director | filed 2006 - 2006 |
| Sager Erich | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hubbard Cristin | EVP, Chief Commercial Officer | filed 2024 - 2026 |
| Friberg Gregory R | EVP, Chief R&D Officer | filed 2024 - 2026 |
| Davis George Eric | VP, General Counsel | filed 2006 - 2026 |
| Mueller Brian | VP, Corporate Controller | filed 2011 - 2026 |
| Guyer Charles Greg | EVP, Chief Technical Officer | filed 2020 - 2026 |
| Ramchandani Rashmi Virendra | VP, Chief Accounting Officer | filed 2026 - 2026 |
| Burkhart Erin | GVP, Chief Accounting Officer | filed 2022 - 2025 |
| Fuchs Henry J | President, Worldwide R&D | filed 2009 - 2024 |
| Ajer Jeffrey Robert | SVP, Chief Commercial Officer | filed 2012 - 2024 |
| Acosta Andrea | GVP, Chief Accounting Officer | filed 2020 - 2021 |
| Baffi Robert | SVP, Technical Operatons | filed 2006 - 2020 |
| Spiegelman Daniel K | EVP, Chief Financial Officer | filed 2012 - 2019 |
| Wood Mark | VP, Human Resources | filed 2007 - 2013 |
| Aselage Steve | SVP, Global Commercial Ops | filed 2006 - 2012 |
| Cooper Jeffrey H | VP, Chief Financial Officer | filed 2006 - 2012 |
| Kakkis Emil D | SVP, Chief Medical Officer | filed 2006 - 2009 |
| Swiedler Stuart J | SVP, Clinical Affairs | filed 2006 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.